FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study

BACKGROUND: FOLFIRINOX and gemcitabine plus nab-paclitaxel (Gem + nabPTX) were recently introduced for metastatic pancreatic cancer treatment. However, studies that compared these two regimens and studies in Asian populations are lacking. AIM: To compare the treatment outcomes of FOLFIRINOX and Gem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastrointest Oncol
Main Authors: Cho, In Rae, Kang, Huapyong, Jo, Jung Hyun, Lee, Hee Seung, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, An, Chansik, Park, Mi-Suk, Bang, Seungmin
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2020
Assuntos:
Retrospective Cohort Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7031147/
https://ncbi.nlm.nih.gov/pubmed/32104549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i2.182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados